AT298690B - Verfahren zur herstellung neuer halogenpregnadiene - Google Patents

Verfahren zur herstellung neuer halogenpregnadiene

Info

Publication number
AT298690B
AT298690B AT00470/70A AT47070A AT298690B AT 298690 B AT298690 B AT 298690B AT 00470/70 A AT00470/70 A AT 00470/70A AT 47070 A AT47070 A AT 47070A AT 298690 B AT298690 B AT 298690B
Authority
AT
Austria
Prior art keywords
pregnadienes
producing new
new halogen
halogen
producing
Prior art date
Application number
AT00470/70A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AT298690B publication Critical patent/AT298690B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R33/00—Coupling devices specially adapted for supporting apparatus and having one part acting as a holder providing support and electrical connection via a counterpart which is structurally associated with the apparatus, e.g. lamp holders; Separate parts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AT00470/70A 1967-11-17 1968-11-15 Verfahren zur herstellung neuer halogenpregnadiene AT298690B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1610167A CH510655A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene

Publications (1)

Publication Number Publication Date
AT298690B true AT298690B (de) 1972-04-15

Family

ID=4414467

Family Applications (3)

Application Number Title Priority Date Filing Date
AT1113168A AT293633B (de) 1967-11-17 1968-11-15 Verfahren zur Herstellung neuer Halogenpregnadiene
AT00470/70A AT298690B (de) 1967-11-17 1968-11-15 Verfahren zur herstellung neuer halogenpregnadiene
AT183070A AT298695B (de) 1967-11-17 1968-11-15 Verfahren zur Herstellung neuer Halogenpregnadiene bzw. -triene

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT1113168A AT293633B (de) 1967-11-17 1968-11-15 Verfahren zur Herstellung neuer Halogenpregnadiene

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT183070A AT298695B (de) 1967-11-17 1968-11-15 Verfahren zur Herstellung neuer Halogenpregnadiene bzw. -triene

Country Status (15)

Country Link
US (1) US3652554A (de)
JP (1) JPS4829221B1 (de)
AT (3) AT293633B (de)
BE (1) BE723905A (de)
BR (1) BR6804024D0 (de)
CH (4) CH534144A (de)
DK (1) DK129835B (de)
FR (2) FR1594773A (de)
GB (1) GB1245292A (de)
MY (1) MY7400317A (de)
NL (1) NL161767C (de)
PL (1) PL80570B1 (de)
SE (1) SE351634B (de)
SU (1) SU424352A3 (de)
YU (4) YU34138B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010458B2 (de) * 1970-02-28 1979-04-26 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 21-Halogensteroide
CH558787A (de) * 1970-12-10 1975-02-14 Ciba Geigy Ag Verfahren zur herstellung eines neuen halogenpregnadiens.
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
NL7502252A (nl) * 1974-02-27 1975-08-29 Pierrel Spa Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
FR2291760A1 (fr) * 1974-11-19 1976-06-18 Pierrel Spa Nouveaux steroides a base de 2-chloro-6 b-fluoro-pregna-1,4-diene-3,20-diones
GB1505701A (en) * 1975-06-14 1978-03-30 Pierrel Spa 2-chloro-6beta-fluoropregnanes
DE2655570A1 (de) * 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Ｉｖ型ホスホジエステラーゼの阻害剤
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
US20110021473A1 (en) * 2006-09-22 2011-01-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
EP2111861A1 (de) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Zusammensetzungen von Phosphodiesterase-IV-Hemmern
CN102827229B (zh) * 2011-06-17 2016-01-20 重庆华邦胜凯制药有限公司 一种纯化卤米松羧酸酯的方法
CN104370987B (zh) * 2014-10-22 2016-09-14 湖南明瑞制药有限公司 一种卤米松的精制方法
CN111944004B (zh) * 2020-09-25 2023-11-17 湖南新合新生物医药有限公司 一种卤米松的制备方法

Also Published As

Publication number Publication date
MY7400317A (en) 1974-12-31
DE1807980B2 (de) 1975-11-06
YU30875A (en) 1982-05-31
YU30775A (en) 1982-05-31
CH510655A (de) 1971-07-31
YU267368A (en) 1978-06-30
YU30675A (en) 1982-05-31
AT298695B (de) 1972-05-25
JPS4829221B1 (de) 1973-09-08
SE351634B (de) 1972-12-04
CH513845A (de) 1971-10-15
NL161767C (nl) 1980-03-17
BE723905A (de) 1969-05-14
US3652554A (en) 1972-03-28
PL80570B1 (de) 1975-08-30
DK129835B (da) 1974-11-25
DE1807980A1 (de) 1969-06-04
SU424352A3 (de) 1974-04-15
CH534144A (de) 1973-02-28
DK129835C (de) 1975-05-05
FR1594773A (de) 1970-06-08
CH540244A (de) 1973-08-15
FR8278M (de) 1970-11-02
YU34138B (en) 1978-12-31
AT293633B (de) 1971-10-25
BR6804024D0 (pt) 1973-01-02
NL6816337A (de) 1969-05-20
GB1245292A (en) 1971-09-08

Similar Documents

Publication Publication Date Title
CH554848A (de) Verfahren zur herstellung neuer stilben-derivate.
AT298690B (de) Verfahren zur herstellung neuer halogenpregnadiene
CH513111A (de) Verfahren zur Herstellung neuer Benz-epinderivate
CH542853A (de) Verfahren zur Herstellung neuer Isothiocyano-benzazol-Derivate
AT285628B (de) Verfahren zur herstellung neuer organosiliziumverbindungen
CH526579A (de) Verfahren zur Herstellung neuer Benziodoxanderivate
CH504425A (de) Verfahren zur Herstellung neuer Bisnorcholanderivate
AT280488B (de) Verfahren zur herstellung neuer digoxinaether
AT294854B (de) Verfahren zur Herstellung neuer D-Glucofuranoside
AT277480B (de) Verfahren zur Herstellung neuer D Homosteroide
CH500972A (de) Verfahren zur Herstellung neuer Spiro-azatetramethylen-Derivate
CH546238A (de) Verfahren zur herstellung neuer indolderivate.
CH510660A (de) Verfahren zur Herstellung neuer Glucofuranoside
CH542229A (de) Verfahren zur Herstellung neuer Benzothiopyranopyridin-derivate
CH529735A (de) Verfahren zur Herstellung neuer 3-Oxo-A-nor-B-homopregnadiene
AT285814B (de) Verfahren zur Herstellung neuer Antibiotika
CH505060A (de) Verfahren zur Herstellung neuer, grenzflächenaktiver N-Acyl-N-alkyl-polyglycerylamine
CH491133A (de) Verfahren zur Herstellung neuer Chinazolinone
AT282078B (de) Verfahren zur Herstellung neuer Nebularin-Derivate
AT287673B (de) Verfahren zur herstellung neuer 1-aminohydroperoxyde
AT286511B (de) Verfahren zur Herstellung neuer 4-Imino-19-nor-A-homo-steroid-triene
AT280502B (de) Verfahren zur Herstellung neuer 3-Oxogonatriene
AT295507B (de) Verfahren zur Herstellung neuer N,N-Diacylamine
AT297952B (de) Verfahren zur Herstellung neuer Halogenpregnadiene
AT299204B (de) Verfahren zur Herstellung neuer Nitrochinazolinone

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee